Opioid Use Disorder Clinical Trials

A listing of Opioid Use Disorder medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 197 clinical trials
Initiating Substance Use Disorder Treatment for Hospitalized Opioid Use Disorder Patients.

The purpose of this 24-week study is to evaluate the impact of recovery coach intervention on rates of treatment retention, illicit opioid use, and readmission among hospitalized patients newly initiated on buprenorphine or methadone compared to the control intervention.

  • 2 views
  • 05 Feb, 2021
Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD)

Use Disorder) by assessing its safety and tolerability in subjects with OUD.

  • 8 views
  • 24 Jan, 2021
  • 1 location
Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine

The purpose of this week-long study is to determine the impact of cannabidiol on cue-induced cravings among individuals with opioid use disorder who are stable on sublingual buprenorphine

  • 0 views
  • 03 Feb, 2021
Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder

Current clinical guidelines for medication assisted treatment (MAT) of opioid use disorder (OUD) recommend that treatment include a psychosocial component to help address psychological factors

buprenorphine
addiction
narcotic use
  • 45 views
  • 26 Jan, 2021
  • 4 locations
Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder

The study is 12-week, randomized, open-label study comparing injectable extended-release buprenorphine (Sublocade) to standard therapy (sublingual buprenorphine), to see if Sublocade will be more helpful in treating opiate use for individuals testing positive for fentanyl and related high potency drugs (HPSO). Those receiving Sublocade will have it administered monthly and …

  • 0 views
  • 27 Jan, 2021
  • 1 location
Intervention Development and Pilot Study to Prevent Untreated Native Hawaiian and Pacific Islander Opioid Use Disorder

This study will design and pilot/feasibility test a culturally grounded intervention to increase the treatment seeking of Pacific Islanders with opioid use disorders in formal services.

  • 0 views
  • 02 Jun, 2021
  • 1 location
Connection Navigation Engagement in Care and Treatment for Opioid Use Disorder

The overarching goal of the study is to develop, pilot, and evaluate an intervention that aims to retain patients who initiate buprenorphine at Denver Health in ongoing treatment for opioid use

  • 0 views
  • 12 Apr, 2021
  • 1 location
OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder

This is an open-label, randomized, parallel-group multicenter study designed to evaluate the efficacy of the digital therapeutic OXD01 (MODIA) combined with sublingual buprenorphine/naloxone standard of care (SL BUP/NAL SOC) background therapy compared to SL BUP/NAL alone to change opioid use patterns in subjects with OUD. Approximately 400 subjects will be …

  • 0 views
  • 25 Jul, 2021
  • 7 locations
Buprenorphine Treatment Engagement and Overdose Prevention

individuals with opioid use disorder initiate and remain in office-based buprenorphine treatment. Investigators propose to develop and pilot test a novel intervention that will combine video-based directly

  • 6 views
  • 17 Feb, 2021
  • 1 location
Medication Maintenance Therapy in Community Pharmacy Settings

The goal of this study is to compare pharmacy-based medication assisted treatment (MAT) with usual care MAT for people with opioid use disorder.

  • 0 views
  • 23 Jan, 2021